$ULBI

WHITMORE BRADFORD T purchased $202K of ULBI (indirect holdings)

WHITMORE BRADFORD T purchased 32,876 indirectly-held shares of ULTRALIFE CORP (ULBI) at $6.13 ($0.20M total) on 2026-05-21.

Original reporting
SEC EDGAR · WHITMORE BRADFORD T
Published May 26, 2026, 8:18 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 26, 2026, 8:25 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ULBI
Bullish
medium confidence
Mentioned
$ULBI
Relevance
7/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ULBIBullishMed
01

Why it matters

This provides a sentiment/positioning datapoint (insider increased holdings) but does not introduce new financial results, contracts, litigation, or product/regulatory milestones.

02

Market read

Traders may treat the disclosure as a small positive signal, but it should not be weighted like earnings or deal news.

03

What to watch

No 10b5-1 plan is cited, but the transaction is indirect and the article lacks context on prior buying/selling cadence or size versus typical insider activity.

Relevance 7/10Timing: Immediate (new Form 4 disclosure filed 2026-05-26; trade signal may be short-lived).

Background

The article is an SEC Form 4 insider transaction disclosure for ULTRALIFE CORP (ULBI).

Company-level read

Ticker impact

$ULBIBullishMedium confidence
Context

ULTRALIFE director/10% owner Whitmore Bradford T bought 32,876 shares for ~$201.7K on 2026-05-21 via an open-market purchase.

Expected impact

Near-term impact likely limited; any move may fade unless followed by earnings/operational news.

Evidence & confidence

The filing is a Form 4 insider transaction with no stated 10b5-1 plan, but the article provides no new business developments or guidance changes.

Market effects

Minimal; this is company-specific insider buying with no sector-wide policy/product/regulatory trigger.

None indicated.

None indicated.

Counterpoint

Insider buys can be routine portfolio rebalancing or driven by liquidity/compensation needs rather than a forward-looking view.

Key entities

  • ULTRALIFE CORP

    Subject of the Form 4 insider open-market purchase disclosed on 2026-05-26.

  • WHITMORE BRADFORD T

    Director and 10% owner who purchased 32,876 shares for ~$201.7K on 2026-05-21.

Related articles

$ULBIMedAI 8/10

Ultralife (ULBI) Q2 2026 Earnings Call Transcript

Ultralife (ULBI) reported Q2 FY2026 revenue of $47.9 million, down 1.3% year over year, with GAAP EPS of $0.15. Gross margin rose to 28.9% on a 500 bps increase, aided by a $1.1 million IEEPA tariff refund. Backlog hit a record $117.5 million, up 39% from a year earlier, and July backlog neared $130 million.

$ULBIMed

ULTRALIFE CORP (ULBI): Results of Operations and Financial Condition

ULTRALIFE CORP (ULBI) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_1001163.htm EXHIBIT 99.1 ex_1001163.htm Exhibit 99.1 Ultralife Corporation Reports Second Quarter Results NEWARK, N.Y. – August 7, 2026 -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the second quarter ended June 30, 2026 with the following re